SAN DIEGO, Feb. 25 /PRNewswire-FirstCall/ -- Bio-Matrix Scientific Group, Inc. announced today that it has added two members to newly created positions on its management team. Feng Lin, M.D., Ph.D. has joined the biotech research and development company as Laboratory/Scientific Director and Marilyn Panahi is serving as Quality Assurance Director.
“Dr. Feng Lin and Marilyn Panahi bring tremendous expertise to the administrative operations of BMSN’s laboratories to ensure all of the varied facets meet government regulations and compliance,” said David Koos, Chairman and CEO, BMSN.
As Laboratory/Scientific Director, Dr. Lin is responsible for the overall operation, leadership, direction, and administration of BMSN’s Laboratory in accordance with Federal and State Regulations governing laboratories.
As Quality Assurance Director, Ms. Panahi is responsible for managing and assuring regulatory compliance requirements including validation, customer complaints, and review of product manufacture records, audits, and quality assurance documentation. .
Dr. Feng Lin has a strong background in drug/DNA in vivo delivery, oncology and tumor immunotherapy, DNA vaccination, cell and molecular biology, and animal model work. He also has extensive experience with tissue imaging, DNA vaccine design, antibody- and cell-based assay. Previously, Dr. Lin was a Senior Research Scientist, Research & Development with Inovio Biomedical Corp., San Diego. He received his M.D. from Central South University Xiag-Ya School of Medicine, Changsha, China, along with a M.S. Biochemistry & Molecular Biology and a Ph.D. Hematology & Physiology from the same institution. Dr. Lin’s research work has been widely published in international scientific journals.
Marilyn Panahi brings more than 15 years experience in the implementation and management of the EPA’s Good Laboratory Practice Standards (GLPS) Compliance Monitoring Program and the FDA’s Good Manufacturing Practices (GMP)/Quality Systems Regulation.
Previously, Ms. Panahi was Quality Manager, Therapheresis, Inc., San Diego. Ms. Panahi is a graduate of San Diego State University with a B.S. in Microbiology. Ms. Panahi also holds a Certificate in Science of Regulatory Affairs for the Drug and Biologic Industry and a Certificate in Quality Assurance/Control for the Drug and Biologic Industry, both from the University of California at San Diego.
About Bio-Matrix Scientific Group, Inc.
Bio-Matrix Scientific Group, Inc., based in San Diego, is a biotech research and development company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market. The company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation. Bio-Matrix’s new 15,000 sq. ft. facility, located in the heart of San Diego’s biotechnology corridor, houses the company’s two secure Cryogenic Stem Cell Banks, three research laboratories, aseptic cellular/tissue class 10,000/100 processing laboratory, hematology, microbiology and flow cytometry laboratories.
CONTACT: David Koos, Chairman & CEO of Bio-Matrix Scientific Group, Inc.,
+1-619-702-1404, Info@BMSN.us
Web site: http://www.BMSN.us/
